Janus Henderson Group Ltd.

13D and 13G Filings

Issuer % of Class Filed
Schedule 13G · 127 securities · passive
Praxis Precision Medicines, Inc 13G/A
PRAX · 74006W207
12.3% 11/14/2025
Event 9/30/2025
Consensus Cloud Solutions, Inc. 13G/A
CCSI · 20848V105
13.1% 11/14/2025
Event 9/30/2025
Api Group Corp 13G
APG · 00187Y100
5.3% 11/14/2025
Event 9/30/2025
Verona Pharma PLC 13G/A
VRNA · 925050106
1.2% 11/14/2025
Event 9/30/2025
Amdocs Limited 13G/A
DOX · G02602103
2.3% 11/14/2025
Event 9/30/2025
Enanta Pharmaceuticals, Inc. 13G
ENTA · 29251M106
12.1% 11/7/2025
Event 10/31/2025
89bio, Inc. 13G/A
ETNB · 282559103
3.6% 10/7/2025
Event 9/30/2025
Aramark 13G/A
ARMK · 03852U106
6.9% 8/14/2025
Event 6/30/2025
Larimar Therapeutics, Inc. 13G/A
LRMR · 517125100
0% 8/14/2025
Event 3/31/2025
OmniAb, Inc. 13G/A
OABI · 68218J103
0.8% 8/14/2025
Event 6/30/2025
Entrada Therapeutics, Inc. 13G/A
TRDA · 29384C108
4.0% 8/14/2025
Event 6/30/2025
The Beauty Health Company 13G/A
SKIN · 88331L108
4.5% 8/14/2025
Event 6/30/2025
Walker & Dunlop, Inc 13G/A
WD · 93148P102
4.6% 8/14/2025
Event 6/30/2025
Globus Medical, Inc. 13G/A
GMED · 379577208
6.1% 5/14/2025
Event 3/31/2025
Mereo Biopharma Group PLC 13G/A
MREO · 589492107
14.3% 5/14/2025
Event 3/31/2025
CARGO Therapeutics, Inc. 13G/A
CRGX · 14179K101
0% 5/14/2025
Event 3/31/2025
Immunome, Inc. 13G/A
IMNM · 45257U108
2.2% 5/14/2025
Event 3/31/2025
Zai Lab Ltd 13G/A
G9887T116
3.6% 5/14/2025
Event 3/31/2025
Blackbaud, Inc. 13G/A
BLKB · 09227Q100
4.3% 5/14/2025
Event 3/31/2025
Perspective Therapeutics, Inc. 13G/A
CATX · 46489V302
0% 2/14/2025
Event 12/31/2024
Applied Therapeutics, Inc. 13G/A
APLT · 03828A101
0% 2/14/2025
Event 12/31/2024
PepGen Inc. 13G/A
PEPG · 713317105
1.6% 2/14/2025
Event 12/31/2024
Caesars Entertainment, Inc. 13G/A
CZR · 12769G100
3.3% 2/14/2025
Event 12/31/2024
Precision BioSciences, Inc. 13G/A
DTIL · 74019P207
0% 2/14/2025
Event 12/31/2024
NeoGenomics, Inc. 13G/A
NEO · 64049M209
4.8% 2/14/2025
Event 12/31/2024
Neurogene Inc. 13G/A
NGNE · 64135M105
0% 2/14/2025
Event 12/31/2024
CytomX Therapeutics, Inc. 13G/A
CTMX · 23284F105
0% 2/14/2025
Event 12/31/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.